DoD recently released Fiscal Year 2023 (FY23) Amyotrophic Lateral Sclerosis Research Program (ALSRP), Breast Cancer Research Program (BCRP), Epilepsy Research Program (ERP), and Peer Reviewed Medical Research Program (PRMRP) funding opportunities for the Department of Defense (DOD) programs managed by the Congressionally Directed Medical Research Programs (CDMRP). CDMRP understands that applicants remain impacted by COVID-19. Submission deadlines for pre-applications and full applications will incorporate the maximum time that is feasible for each FY23 program. Thank you for your efforts during this challenging time.
FY23 Funding Opportunities released:
Amyotrophic Lateral Sclerosis Research Program
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Funding Opportunities/Program Announcements and General Application Instructions which can be found on the Grants.gov website (https://Grants.gov). A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using Assistance Listing (formerly CFDA) Number 12.420.
For email notification when CDMRP funding opportunities are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil). For more information on types of funding opportunities offered and application strategies review the CDMRP Webinar Series: https://cdmrp.army.mil/pubs/Webinars/webinar_series.